6533b7dcfe1ef96bd1272b47
RESEARCH PRODUCT
The FDA Approves Aducanumab for Alzheimer's Disease, Raising Important Scientific Questions1.
Francisco Gonzalez-limaJack C. De La TorreJack C. De La Torresubject
medicine.medical_specialtyDrug Industrybusiness.industryGeneral NeuroscienceMEDLINEGeneral MedicineDiseaseAntibodies Monoclonal HumanizedRaising (linguistics)United StatesPsychiatry and Mental healthClinical PsychologyAlzheimer DiseaseMedicineHumansAducanumabGeriatrics and GerontologybusinessIntensive care medicineDrug Approvalyear | journal | country | edition | language |
---|---|---|---|---|
2021-08-03 | Journal of Alzheimer's disease : JAD |